Tag Archives: NYSE:SYK

Stryker Corporation (SYK): New Buy Recommendation for This Healthcare Giant

In a report released yesterday, Ryan Zimmerman from BTIG assigned a Buy rating to Stryker Corporation (NYSE: SYK), with a price target of $187. The company’s shares closed yesterday at $171.76. Zimmerman observed: “Adding Photonics to its Instrument Offerings This

Needham Remains a Hold on Stryker Corporation (SYK)

Needham analyst Michael Matson maintained a Hold rating on Stryker Corporation (NYSE: SYK) today. The company’s shares opened today at $170.22. Matson commented: “SYK is acquiring Invuity (IVTY) for $7.40 per share (a 29% premium) or ~$190M of cash which

Analysts Offer Insights on Healthcare Companies: Stryker Corporation (NYSE: SYK) and Nevro (NYSE: NVRO)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Stryker Corporation (NYSE:SYK) and Nevro (NYSE:NVRO) with bullish sentiments. Stryker Corporation (SYK) In a report released yesterday, Kyle Rose from Canaccord Genuity

RBC Capital Reiterates a Buy Rating on Stryker Corporation

In a report released today, Glenn Novarro from RBC Capital reiterated a Buy rating on Stryker Corporation (NYSE: SYK), with a price target of $184. The company’s shares closed yesterday at $172.92, close to its 52-week high of $179.84. According

Needham Maintains Their Hold Rating on Stryker Corporation

In a report released today, Michael Matson from Needham maintained a Hold rating on Stryker Corporation (NYSE: SYK). The company’s shares closed yesterday at $172.92, close to its 52-week high of $179.84. Matson noted: “SYK’s 2Q18 revenue met consensus while

BMO Capital Remains a Hold on Stryker Corporation

In a report issued on July 10, Joanne Wuensch from BMO Capital reiterated a Hold rating on Stryker Corporation (NYSE: SYK), with a price target of $174. The company’s shares closed yesterday at $173.42, close to its 52-week high of